| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.08▼ | 3.05▲ | 3.03▲ | 2.98▲ | 2.84▲ |
| MA10 | 3.07▼ | 3.01▲ | 2.95▲ | 2.88▲ | 2.88▲ |
| MA20 | 3.06▼ | 2.94▲ | 2.92▲ | 2.77▲ | 2.55▲ |
| MA50 | 2.96▲ | 2.93▲ | 2.96▲ | 2.89▲ | 1.90▲ |
| MA100 | 2.92▲ | 2.93▲ | 2.78▲ | 2.47▲ | 2.00▲ |
| MA200 | 2.93▲ | 2.76▲ | 2.79▲ | 1.88▲ | 1.62▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.006▼ | 0.020▲ | 0.022▲ | 0.042▲ | -0.002▼ |
| RSI | 59.405▲ | 70.286▲ | 66.167▲ | 59.173▲ | 65.162▲ |
| STOCH | 29.762 | 92.306▲ | 92.346▲ | 66.530 | 32.405 |
| WILL %R | -85.714▼ | -19.355▲ | -19.355▲ | -24.242▲ | -64.589 |
| CCI | -34.028 | 101.477▲ | 134.139▲ | 85.812 | 31.480 |
|
Tuesday, October 27, 2026 01:00 AM
Dr. Arjona Ferreira currently serves as Head of Research and Development and Chief Medical Officer at Organon & Co. (NYSE: OGN)He joins ...
|
|
Gilead's Latest Deal Shows Big Pharma's Appetite for Oral Peptides. Which Stocks Are Worth Watching?
Monday, October 26, 2026 03:57 AM
WSW, NY, October 26th, 2026, FinanceWireIts $1.275 billion upfront commitment to a Phase 1 program puts the spotlight on ...
|
|
Tuesday, October 06, 2026 05:00 PM
The former Gilead and Amgen commercial leader takes her seat as Entera’s Phase 3 trial nears its initiation. Entera Bio Ltd. (NASDAQ:ENTX), a clinical-stage developer of oral peptide therapies, ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 27/10/26 | 2.86 | 3.12 | 2.855 | 3.06 | 198,143 |
| 26/10/26 | 2.90 | 2.90 | 2.80 | 2.86 | 232,466 |
| 23/10/26 | 2.99 | 3.02 | 2.86 | 2.92 | 256,927 |
| 22/10/26 | 3.01 | 3.04 | 2.9007 | 3.02 | 629,476 |
| 21/10/26 | 3.12 | 3.20 | 2.96 | 3.05 | 784,597 |
| 20/10/26 | 2.79 | 3.26 | 2.79 | 3.02 | 791,927 |
| 19/10/26 | 2.66 | 2.97 | 2.62 | 2.94 | 953,139 |
| 16/10/26 | 2.72 | 2.75 | 2.62 | 2.68 | 572,891 |
| 15/10/26 | 2.49 | 2.82 | 2.49 | 2.77 | 1,447,906 |
| 14/10/26 | 2.47 | 2.565 | 2.46 | 2.50 | 784,486 |
|
|
||||
|
|
||||
|
|